2025
|
Invention
|
Film coating composition and solid preparation.
The present invention provides a film coating co... |
|
Invention
|
Method for selecting additive for suppressing nitrosation reaction, and formulation for suppressi... |
|
Invention
|
Method for quantifying reactive nox, and formulation for suppressing generation of nitroso compou... |
|
Invention
|
Dosage form having identification information, method for manufacturing same, pestle for use in m... |
|
Invention
|
Pharmaceutical composition comprising enzalutamide solid dispersion, and formulation comprising s... |
|
Invention
|
Solid dispersion, preparation containing solid dispersion, and method for producing solid dispers... |
2024
|
Invention
|
Sitagliptin preparation and method of storage thereof.
An embodiment of the present invention pr... |
|
Invention
|
Granules, granule-containing pharmaceutical preparation, and granule-containing food. One of the ... |
|
Invention
|
Enzalutamide solid dispersion and method for producing same, and enzalutamide-containing preparat... |
|
Invention
|
Prasugrel hydrochloride-containing formulation. One embodiment of the present invention provides ... |
|
Invention
|
Stephania cepharantha-derived alkaloid-containing preparation.
In an embodiment, a Stephania cep... |
|
Invention
|
Dose sensation evaluation method, dose sensation evaluation device, and non-transitory computer r... |
|
Invention
|
Teneligliptin-containing preparation. One problem addressed by one embodiment of the present inve... |
|
P/S
|
Pharmaceutical preparations for medical or veterinary purposes for the prevention and treatment o... |
|
P/S
|
Pharmaceutical preparations. |
|
Invention
|
Teneligliptin-containing particles and formulation containing same. One problem to be addressed b... |
2023
|
Invention
|
Method for selecting additive capable of inhibiting nitrosation reaction, and preparation prevent... |
|
Invention
|
Preparation containing saxagliptin and method for producing the same. A preparation containing sa... |
|
Invention
|
Method for producing fesoterodine fumarate-containing formulation. One embodiment of the present ... |
2022
|
Invention
|
Medicinal preparation containing apremilast hydrate. A medicinal preparation containing an apremi... |
|
Invention
|
Granules and preparation using same.
Provided is a melt granulated product with a high particle ... |
|
Invention
|
Granules and preparation using same.
According to one embodiment of the present invention, granu... |
|
Invention
|
Film-coated granule, pharmaceutical preparation containing the same, and manufacturing methods th... |
|
Invention
|
Stephania cephalantha-derived alkaloid-containing preparation. In one embodiment, provided is a S... |
|
Invention
|
Solid preparation containing tafamidis and method for producing the same.
A solid preparation co... |
2021
|
Invention
|
Method for manufacturing orally disintegrating tablet, and orally disintegrating tablet.
A metho... |
|
Invention
|
Linagliptin-containing orally disintegrating tablet. The present invention provides: a linaglipti... |
|
Invention
|
Granule, preparation containing the granule, production method of the granule, and production met... |
|
Invention
|
Granules and preparation using same. Provided is a melt granulated substance with a high grain si... |
|
Invention
|
Granules and preparation using same. An embodiment of the present invention provides granules wit... |
|
Invention
|
Method for producing granules containing a core particle, granules containing a core particle, ph... |
2020
|
Invention
|
Vildagliptin-containing dry granulated powder, vildagliptin-containing tablet, and methods for pr... |
|
Invention
|
Method for manufacturing orally disintegrating tablet, and orally disintegrating tablet. Provided... |
|
Invention
|
Anhydrous dasatinib-containing preparation. An anhydrous dasatinib-containing preparation compris... |
|
Invention
|
Film coating composition and solid preparation. The present invention provides a film coating com... |
2019
|
Invention
|
Sustained-release preparation containing pseudoephedrine or a pharmaceutically acceptable salt th... |
|
Invention
|
Additive composition for orally disintegrating tablet. Provided is a novel additive for an orally... |
|
Invention
|
Mouthfeel evaluation method and mouthfeel evaluation apparatus for orally disintegrating test obj... |
|
Invention
|
Orally disintegrating tablet coated with film. Provided is an orally disintegrating tablet film-c... |
2018
|
Invention
|
Anhydrous dasatinib-containing preparation. Provided is an anhydrous dasatinib-containing prepara... |
|
Invention
|
Orally disintegrating tablet evaluating method, and orally disintegrating tablet evaluating devic... |
|
Invention
|
Mirabegron-containing tablet, method for producing mirabegron-containing pharmaceutical preparati... |
2017
|
P/S
|
Chemicals and chemical preparations for use in the manufacture of pharmaceuticals Pharmaceutical ... |
|
P/S
|
Pharmaceuticals. |
|
P/S
|
Chemicals. Pharmaceuticals (not for agriculture purposes). Banners of paper; paper bunting; hygie... |
|
Invention
|
Orally disintegrating tablet additive composition. Provided are: a novel orally disintegrating ta... |
|
Invention
|
Texture evaluation method and texture evaluation apparatus for orally disintegrable test object. ... |
|
Invention
|
Additive composition for orally disintegrating tablet. Provided are: a novel additive which is fo... |
|
Invention
|
Intraorally disintegrable tablet containing olmesartan medoxomil. Provided is an intraorally disi... |
2016
|
Invention
|
Gefinitib-containing tablet. The purpose of the present invention is to provide a gefinitib-conta... |
2011
|
P/S
|
Prescription pharmaceutical preparations. |